BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30251730)

  • 1. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
    Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
    Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
    Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
    PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
    Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
    Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.
    Marini BL; Hough SM; Gregg KS; Abu-Seir H; Nagel JL
    Support Care Cancer; 2015 Aug; 23(8):2287-95. PubMed ID: 25576429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Common Bacterial and Fungal Pathogens in Children with Hematological Malignancies during Febrile Neutropenia: Single Center Egyptian Study.
    Hagag AA; Hassan SM; Elgamasy MA; Afifi IK
    Infect Disord Drug Targets; 2016; 16(1):54-62. PubMed ID: 26715443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.
    Mori M; Tsunemine H; Imada K; Ito K; Kodaka T; Takahashi T
    Ann Hematol; 2014 Jun; 93(6):901-11. PubMed ID: 24535696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
    Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
    J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
    Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections of febrile neutropenic patients in malignant hematological diseases.
    Rókusz L; Liptay L
    Mil Med; 2003 May; 168(5):355-9. PubMed ID: 12775168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India.
    Ghosh S; Chakraborty M; Samanta S; Sinha N; Saha S; Chattopadhyay A; Roy SS; Bhattacharyya M
    Ann Hematol; 2021 Feb; 100(2):395-403. PubMed ID: 33140134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
    Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
    Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.
    Todeschini G; Franchini M; Tecchio C; Meneghini V; Pizzolo G; Veneri D; Murari C; Ricetti MM; Perona G
    Int J Infect Dis; 1998-1999 Winter; 3(2):99-104. PubMed ID: 10225988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study.
    Al-Tawfiq JA; Hinedi K; Khairallah H; Saadeh B; Abbasi S; Noureen M; Raza S; Alkhatti A
    J Infect Public Health; 2019; 12(3):364-366. PubMed ID: 30594483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.